# Theriva Biologics (TOVX) — Analyst Forecast

TOVX · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/tovx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 2 | 0 | 0 | 2 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Mar 31, 2026 | Maxim Group | Upgraded | Hold → Buy | $1.00 |
| May 8, 2025 | Maxim Group | Downgraded | Buy → Hold | — |
| Nov 13, 2024 | Maxim Group | Maintained | Buy | $6.00 |

## Frequently Asked Questions

### Is TOVX a buy, sell, or hold?

Analysts covering Theriva Biologics currently average a Buy rating: 2 buy, 0 hold and 0 sell, from 2 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on TOVX?

On Mar 31, 2026, Maxim Group upgraded Theriva Biologics to Buy with a price target of $1.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).